TP53 and hematologic disorder: For example, miR-125b is an onco-miR in hematologic malignancies as it targets p53 [74] and other components of the p53 pro-apoptotic network, including BAK1, PUMA, BMF, TRP53INP1 and Krupple-like factor 13 (KLF13) [75, 76].